Loading
No description yet: the sentence for this tag has not been written. 3 records carry it: 3 people. Also written “drug delivery”; the spellings share this page.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Alberto Gabizon Oncologist, Shaare Zedek Medical Center; professor, Hebrew University-Hadassah Medical School · Shaare Zedek Medical Center The clinician half of the partnership that turned a liposome chemistry idea into Doxil, and the person who did the trials that showed it behaved differently in patients from free doxorubicin. | Ovarian cancer, Kaposi sarcoma | none | clinician-scientist | ||
Robert S. Langer David H. Koch (1962) Institute Professor · David H. Koch Institute for Integrative Cancer Research at MIT Biomedical engineer whose Koch Institute lab pioneered controlled drug delivery and nanomedicine, including approaches to cancer therapy. | none | none | clinician-scientist, nanomedicine | ||
Yechezkel Barenholz Professor, Laboratory of Membrane and Liposome Research, Hebrew University-Hadassah Medical School · Hebrew University of Jerusalem Invented the chemistry that made Doxil work, the first nanomedicine any regulator approved, which is still a standard treatment for relapsed ovarian cancer three decades later. | Ovarian cancer, Kaposi sarcoma | none | scientist |